logo

For the Inventor, By the Inventor

Lexington, KY, United States of America

Don Marshall Gash

This inventor holds 5 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: University of Kentucky Research Foundation, Amgen Inc., Northern Bristol N.h.s. Trust Frenchay Hospital. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Don Marshall Gash. Retrieved from https://idiyas.com/inventor/don-marshall-gash

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Lexington-Fayette, KY (US) (2015)
  • Lexington, KY (US) (2015 - 2023)

Company Filing History:

goldMedal5 out of 904 
 
University of Kentucky Research Foundation
 patents
silverMedal2 out of 2,084 
 
Amgen Inc.
 patents
bronzeMedal1 out of 1 
 
Northern Bristol N.h.s. Trust Frenchay Hospital
 patent
where one patent can have more than one assignee

Years Active: 2015-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 11833185 - Anti-neurodegenerative therapeutic, method of manufacture, and use (2023-12-05),
2. 9586992 - Amidated dopamine neuron stimulating peptides for CNS dopaminergic upregulation (2017-03-07),
3. 9402875 - Amidated dopamine neuron stimulating peptide restoration of mitochondrial activity (2016-08-02),
4. 8946152 - Method of treating parkinson's disease in humans by convection-enhanced infusion of glial cell-line derived neurotrophic factor to the putamen (2015-02-03),
5. 8946151 - Method of treating Parkinson's disease in humans by convection-enhanced infusion of glial cell-line derived neurotrophic factor to the putamen (2015-02-03),

Title: Don Marshall Gash: Innovator in Neurodegenerative Therapeutics

Introduction

Don Marshall Gash is a prominent inventor based in Lexington, KY (US), known for his significant contributions to the field of neurodegenerative therapeutics. With a total of five patents to his name, Gash has focused on developing innovative methods and therapeutic peptides aimed at treating brain diseases and injuries.

Latest Patents

Gash's latest patents include an anti-neurodegenerative therapeutic, which discloses a method of manufacture and use of therapeutic peptides with specific amino acid sequences. These peptides are designed to treat neurodegenerative disorders and injuries by administering a therapeutically effective amount to affected individuals. Another notable patent involves amidated dopamine neuron stimulating peptides, which are useful for addressing dopaminergic deficiencies in brain diseases and injuries.

Career Highlights

Throughout his career, Gash has worked with esteemed organizations such as the University of Kentucky Research Foundation and Amgen Inc. His work has significantly advanced the understanding and treatment of neurodegenerative conditions, showcasing his dedication to improving human health.

Collaborations

Gash has collaborated with notable colleagues, including Greg A. Gerhardt and Luke H. Bradley, contributing to a rich exchange of ideas and research in the field of neurobiology.

Conclusion

Don Marshall Gash's innovative work in neurodegenerative therapeutics highlights his commitment to advancing medical science. His patents and collaborations reflect a deep understanding of the complexities of brain health and the potential for therapeutic interventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…